Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,289 public trials 413 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Recruiting

Blue Light Cystoscopy With Cysview® Registry

NCT02660645

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 23 locations
View Trial Details
Recruiting

A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer

NCT05327647

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • London Health Sciences Centre London, Ontario, Canada
  • University Health Network, Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • Centre intégré de santé et services sociaux de Chaudière Appalaches Lévis, Quebec, Canada
  • Centre Hospitalier de l'Université De Montréal_CHUM Montreal, Quebec, Canada
View Trial Details
Recruiting

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

NCT06263153

Conditions
Bladder Urothelial Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Recruiting

Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma

NCT06091124

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Jiangsu Province Hospital Nanjing, Jiangsu, China
  • The First Affiliated Hospital of Xi'an Jiao Tong University Xi'an, Shaanxi, China
  • RenJi Hospital Shanghai, Shanghai Municipality, China
  • West China Hospital Chengdu, Sichuan, China
View Trial Details

Related conditions